Robert B. Epstein

3.6k total citations · 1 hit paper
83 papers, 2.7k citations indexed

About

Robert B. Epstein is a scholar working on Hematology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert B. Epstein has authored 83 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 22 papers in Genetics and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert B. Epstein's work include Hematopoietic Stem Cell Transplantation (18 papers), Mesenchymal stem cell research (17 papers) and Virus-based gene therapy research (15 papers). Robert B. Epstein is often cited by papers focused on Hematopoietic Stem Cell Transplantation (18 papers), Mesenchymal stem cell research (17 papers) and Virus-based gene therapy research (15 papers). Robert B. Epstein collaborates with scholars based in United States, France and Netherlands. Robert B. Epstein's co-authors include Rainer Storb, E. Donnall Thomas, Haakon Ragde, E. Donnall Thomas, E. Donnall Thomas, T. C. Graham, Jean I. Bryant, Robert H. Rudolph, Rainer Storb and E D Thomas and has published in prestigious journals such as Science, New England Journal of Medicine and The Journal of Experimental Medicine.

In The Last Decade

Robert B. Epstein

83 papers receiving 2.3k citations

Hit Papers

METHOTREXATE REGIMENS FOR CONTROL OF GRAFT-VERSUS-HOST DI... 1970 2026 1988 2007 1970 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert B. Epstein United States 30 1.2k 624 479 466 456 83 2.7k
GW Santos United States 35 2.5k 2.0× 825 1.3× 554 1.2× 950 2.0× 342 0.8× 95 3.6k
P. J. Tutschka United States 32 2.0k 1.6× 738 1.2× 344 0.7× 1.2k 2.6× 365 0.8× 95 3.8k
Andreas Hirt Switzerland 26 1.3k 1.1× 598 1.0× 430 0.9× 856 1.8× 311 0.7× 89 3.1k
Geoffrey P. Herzig United States 29 1.7k 1.4× 1.3k 2.2× 633 1.3× 517 1.1× 259 0.6× 68 3.8k
L Schwarzenberg France 25 870 0.7× 1.2k 2.0× 384 0.8× 789 1.7× 340 0.7× 176 3.0k
R Clift United States 23 1.9k 1.5× 870 1.4× 554 1.2× 649 1.4× 139 0.3× 43 2.7k
William E. Beschorner United States 25 1.2k 1.0× 607 1.0× 302 0.6× 657 1.4× 355 0.8× 44 2.6k
M Carotenuto Italy 26 1.1k 0.9× 680 1.1× 609 1.3× 542 1.2× 144 0.3× 81 2.2k
Gerald J. Elfenbein United States 29 1.5k 1.2× 1.0k 1.6× 356 0.7× 696 1.5× 202 0.4× 97 3.2k
Lerner Kg United States 12 1.6k 1.3× 494 0.8× 283 0.6× 674 1.4× 161 0.4× 18 2.1k

Countries citing papers authored by Robert B. Epstein

Since Specialization
Citations

This map shows the geographic impact of Robert B. Epstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert B. Epstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert B. Epstein more than expected).

Fields of papers citing papers by Robert B. Epstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert B. Epstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert B. Epstein. The network helps show where Robert B. Epstein may publish in the future.

Co-authorship network of co-authors of Robert B. Epstein

This figure shows the co-authorship network connecting the top 25 collaborators of Robert B. Epstein. A scholar is included among the top collaborators of Robert B. Epstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert B. Epstein. Robert B. Epstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cherry, Mohamad, et al.. (2010). Successful Autologous Stem Cell Transplant After 21 Years of Cryopreservation.. Blood. 116(21). 4603–4603. 1 indexed citations
2.
Awasthi, Vibhudutta, et al.. (2009). F-18-fluorothymidine-PET evaluation of bone marrow transplant in a rat model. Nuclear Medicine Communications. 31(2). 152–158. 8 indexed citations
3.
Weissman, David E., et al.. (2005). Best Cases from the AFIP. Radiographics. 25(1). 243–248. 36 indexed citations
4.
Lerner, Megan R., et al.. (2003). A rat model of syngeneic bone marrow transplantation during breast cancer therapy. Bone Marrow Transplantation. 31(11). 1037–1041. 2 indexed citations
5.
Buckner, CD, Robert B. Epstein, Robert H. Rudolph, et al.. (2001). Allogeneic Marrow Engraftment Following Whole Body Irradiation in a Patient with Leukemia. Journal of Hematotherapy & Stem Cell Research. 10(2). 201–208. 35 indexed citations
6.
Epstein, Robert B., et al.. (1992). A CANINE MODEL FOR HEPATIC VENOOCCLUSIVE DISEASE. Transplantation. 54(1). 12–16. 16 indexed citations
7.
Kuebler, J. Philip, et al.. (1990). Synergistic Effects of Vinblastine and Recombinant Interferon-β on Renal Tumor Cell Lines. Journal of Interferon Research. 10(3). 281–291. 3 indexed citations
9.
Thigpen, J.T., Harry E. Hynes, William A. Nahhas, et al.. (1987). A Phase II Trial of Vinblastine in Patients with Advanced or Recurrent Endometrial Carcinoma A Southwest Oncology Group Study. American Journal of Clinical Oncology. 10(5). 429–431. 6 indexed citations
10.
Alberts, David S., Stephanie Green, John D. Cowan, et al.. (1987). Phase II evaluation of bisantrene hydrochloride in refractory malignant melanoma. Investigational New Drugs. 5(3). 289–292. 2 indexed citations
11.
Gallucci, Betty B., Robert B. Epstein, G E Sale, et al.. (1982). The fine structure of human rectal epithelium in acute graft-versus-host disease. The American Journal of Surgical Pathology. 6(4). 293–306. 52 indexed citations
12.
Epstein, Robert B., et al.. (1979). Processing of peripheral blood stem cells for transplantation.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 7 Suppl 5. 125–34. 8 indexed citations
13.
Beschorner, William E., Allan D. Hess, S. T. Nerenberg, & Robert B. Epstein. (1979). Isolation and characterization of canine venereal tumor-associated inhibitory and blocking factors.. PubMed. 39(10). 3920–7. 10 indexed citations
14.
Hess, Allan D., et al.. (1977). Intralesional Bacillus Calmette-Guérin immunotherapy of canine venereal tumors.. PubMed. 37(11). 3990–4. 12 indexed citations
15.
Hess, Allan D., et al.. (1976). Intralesional BCG immunotherapy of canine venereal tumors. Clinical research. 24(4). 1 indexed citations
16.
Epstein, Robert B., Frank J. Waxman, Bruce Bennett, & B. R. Andersen. (1974). Pseudomonas Septicemia in Neutropenic Dogs I. Treatment with Granulocyte Transfusions. Transfusion. 14(1). 51–57. 42 indexed citations
17.
Rood, J. J. van, et al.. (1973). CONSEQUENT INTRAFAMILIAL IMMUNIZATION FOR DL-A HAPLOTYPING IN CANINES. The Journal of Experimental Medicine. 137(2). 494–503. 7 indexed citations
18.
Storb, Rainer, et al.. (1969). Brief Report: Transplantation of Allogeneic Canine Bone Marrow Stored at -80 C. in Dimethyl Sulfoxide. Blood. 33(6). 918–923. 29 indexed citations
19.
Epstein, Robert B., Reginald A. Clift, & E. Donnall Thomas. (1969). The Effect of Leukocyte Transfusions on Experimental Bacteremia in the Dog. Blood. 34(6). 782–790. 36 indexed citations
20.
Heller, Paul, et al.. (1963). Variation in the Amount of Hemoglobin S in a Patient with Sickle Cell Trait and Megaloblastic Anemia. Blood. 21(4). 479–483. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026